Genomics-driven cancer therapeutics has gained prominence in personalized cancer treatment. However, its utility in indications lacking biomarker-driven treatment strategies remains...

Onco-PDO test minimizes side effects and wasted resources from unnecessary treatments and provides a key datapoint to drive more informed clinical decisions.